Tag: Hutchinson-Gilford Progeria Syndrome.

ZOKINVY (lonafarnib), the only FDA Approved Treatment for Hutchinson-Gilford Progeria Syndrome, Now Exclusively Available at Biologics by McKesson

Biologics by McKesson became the exclusive specialty pharmacy for ZOKINVY, the only FDA-approved treatment to reduce mortality risk in Hutchinson-Gilford Progeria Syndrome.